Abbott Laboratories

ABTNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$178.195 B

$102.98 +0.36%

Close of 21 Sept 2026

Revenue

$44.3B

#95 by revenue

Earnings

$6.52B

#80 by earnings

Shares outstanding

1,730,383,296

Latest filing cover page

P/E ratio

27.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#5NovartisNVS$269.0B
#6AstrazenecaAZN$260.7B
#7Abbott LaboratoriesABT$178.2B
#8Novo Nordisk A SNVO$176.2B
#9PfizerPFE$158.1B

What if Abbott Laboratories were worth as much as…

Open the what-if tool →

Gold $30.3T

$17,495.58

Per share 170× higher

Bitcoin $1.72T

$993.89

Per share 9.65× higher

Nvidia $5.48T

$3,166.85

Per share 30.8× higher

Or at a round number

$500.0B $1.00T $2.00T $5.00T

Where these numbers come from

Share counts and financials for Abbott Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.